On the eve of a planned $75 initial public offering, Chelsea biotech firm Civitas Therapeutics has been acquired by an Ardsley, NY-based biotech for $525 million.
http://ift.tt/1mRCiou
http://ift.tt/1mRCiou
Ardsley News: Local news for Ardsley, NY continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment